公司資料
Fusion Pharmaceuticals Inc. 股價、新聞與催化劑
- 股票代碼:
- FUSN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Canada and listed in the U
股價為何變動
目前無法取得 FUSN 的收盤價變動背景。
公司概覽
業務概覽
Fusion Pharmaceuticals was a radiopharmaceutical oncology company focused on targeted alpha therapies before being acquired. Its story centered on the growing interest in precision radiotherapeutics for cancer.
所在地與產業分類
Fusion was headquartered in Canada and listed in the U.S. market. It sat in oncology biotechnology and radiopharmaceuticals.
商業模式特徵
The company depended on clinical progress, manufacturing, and strategic value in a fast-growing modality. Investors watched data, target selection, and deal interest.
生技產業定位
Fusion belongs to the historical radiopharma M&A bucket. It was a high-interest oncology platform before acquisition because the modality was gaining momentum.
未來催化劑
- Fusion is now largely a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. There is no live standalone pipeline left.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。